Page 7 - Capital Commitment News Today

Leuven, BELGIUM, Boston, MA, US - November 4, 2022 - 7 PM CET Oxurion NV(Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies

Negma Group has converted 120 convertible bonds in Oxurion resulting in a EUR 300,000 capital increase. This is part of Negma Group's EUR 30 million Capital Commitment1 that will allow Oxurion

Investegate announcements from Oxurion NV, Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA

Investegate announcements from Oxurion NV, Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA

Negma Group hasconverted580convertible bonds in Oxurion resulting in a EUR1,450,000capital increase. This is part of Negma Group’s EUR 30 million Capital Commitment 1 that will allow Oxurion to focus on

Negma Group has converted 580 convertible bonds in Oxurion resulting in a EUR 1,450,000 capital increase. This is part of Negma Group's EUR 30 million Capital Commitment1 that will allow Oxurion

Negma Group has converted 580 convertible bonds in Oxurion resulting in a EUR 1,450,000 capital increase. This is part of Negma Group’s EUR 30 million...

Investegate announcements from Oxurion NV, Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA

Negma Group has converted 160 convertible bonds in Oxurion resulting in a EUR 400,000 capital increase. This is part of Negma Group's EUR 30 million Capital Commitment1 that will allow Oxurion to

Negma Group has converted 200 convertible bonds in Oxurion resulting in a EUR 500,000 capital increase. This is part of Negma Group's EUR 30 million Capital Commitment1 that will allow Oxurion to